QUICKLINKS AND VIEW OPITONS
Symlin (pramlintide) caused nausea in 9-29% of patients depending on dose
Thursday, September 11, 2008 11:21 am Email this article
Symlin (pramlintide) caused nausea in 9 percent of patients given 240 mcg three times per day and 29 percent of patients given 360 mcg three times per day versus 2 percent of those given a placebo. REFERENCE
Smith S, Aronne L, Burns C, Kesty N, Halseth A, Weyer C. Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care. 2008 Sep, 31(9):1816-23.
AUTHOR’S CONTACT INFORMATION
Christian Weyer, MD
San Diego, California USA
Steve R. Smith, MD
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, Louisiana USA
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.